Found: 7
Select item for more details and to access through your institution.
Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failure.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
- Published in:
- Diabetic Medicine, 2002, v. 19, n. 9, p. 790, doi. 10.1046/j.1464-5491.2002.00657_1.x
- By:
- Publication type:
- Article
Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
- Published in:
- 1994
- By:
- Publication type:
- journal article